News

Fighting leukemia by breaking a hidden cell loop
Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...
In-body CAR-T cell generation proves effective, safe in mice in Stanford Medicine-led study
RNA bundled in lipid nanoparticles trains T cells in mice to eliminate cancer. Coupled with noninvasive imaging, researchers ...
CURE2d
Breaking Down What CAR T-Cell Therapy Means for Blood Cancers
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...
New leukemia drug offers hope for Iowa family and others
A groundbreaking drug, blinatumomab, is transforming leukemia treatment, offering new hope for patients like 4-year-old Madi ...
The Manila Times1d
ImCheck’s ICT01 Receives FDA Orphan Drug Designation for Treatment of Acute Myeloid Leukemia
ImCheck’s ICT01 Receives FDA Orphan Drug Designation Clinical data showing unprecedented remission rates in newly diagnosed ...
Indianapolis Recorder1d
IU researchers develop promising strategy to target leukemia stem cells
Scientists at Indiana University School of Medicine have identified a new approach that could transform treatment for acute ...
News-Medical.Net on MSN4d
New immunotherapy targets leukemia at its root
Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...
Targeted Oncology4d
Immunotherapy Advances and Challenges in T-Cell Lymphoma
Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...
Oncology Nurse Advisor1d
Late Autologous Stem Cell Transplantation May Be Effective in Patients With ALL
The patients receiving AHSCT had 5-year LFS of 46.3% and OS of 53.3%, which were better outcomes than those of the MRC UKALL XII/ECOG E2993 trial conducted from 2006 to 2010.